Continual Improvement
What a definition is not
A definition is SPEQ’s plain-language decode of how a term is used in practice, cited to the documents that define it. It is a practitioner reference, not legal or regulatory advice, it does not replace the definition in the source, and where a regulator’s wording differs the regulator’s wording governs.
The pharmaceutical quality system element and management principle of systematically enhancing process performance, product quality, and the quality system itself, using inputs such as quality metrics, trending data, CAPA outcomes, and management review, rather than treating the quality system as a static, once-built compliance baseline.
ICH Q10 names continual improvement of process performance and product quality as one of the four enablers layered on top of the ICH Q8/Q9/Q10 pharmaceutical quality system, alongside knowledge management and quality risk management — it is meant to operate throughout the product lifecycle, not just during initial development or immediately after a finding.
In practice, continual improvement draws on process capability trending, deviation and complaint trending, internal audit findings, and CAPA effectiveness data to identify opportunities that go beyond simply fixing what broke — for example tightening a process parameter range that has been consistently well within limits, or simplifying a procedure that repeatedly generates minor deviations.
A quality system that only ever reacts to individual nonconformances, without a mechanism for proactively identifying improvement opportunities from aggregated data, falls short of the continual-improvement expectation even if every individual CAPA is well executed.
- —One of the four ICH Q10 enablers layered onto the pharmaceutical quality system
- —Draws on trending data, CAPA effectiveness, and internal audit findings
- —Distinct from reactive fixing — includes proactive opportunity identification
- —Expected to operate across the full product lifecycle
ICH Q10; ISO 9001:2015 Clause 10.3 (Continual improvement)
Frequently asked questions
What is Continual Improvement?
The pharmaceutical quality system element and management principle of systematically enhancing process performance, product quality, and the quality system itself, using inputs such as quality metrics, trending data, CAPA outcomes, and management review, rather than treating the quality system as a static, once-built compliance baseline.
Which regulations cover Continual Improvement?
ICH Q10; ISO 9001:2015 Clause 10.3 (Continual improvement)